Hypodermic Needle Injection (IMAGE) St. John's College, University of Cambridge Caption GLP-1 Agonists are injectable drugs that regulate blood sugar levels and have also been shown to promote weight loss, making them an attractive form of treatment for type 2 diabetes, which is often linked to obesity. Credit Credit: <a target="_blank"href="https://www.flickr.com/photos/stevendepolo/3021193208">Steven Depolo via Flickr</a> Usage Restrictions Respect terms of <a target="_blank"href="https://creativecommons.org/licenses/by/2.0/">Attribution 2.0 Generic (CC BY 2.0)</a> License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.